HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association between C-reactive protein levels in the first 1-3 days post-transplant and allogeneic immune reactions.

AbstractAIM:
The purpose of this study was to determine whether C-reactive protein (CRP) in the first 1-3 days post-transplant could predict allogeneic immune reactions, including engraftment syndrome or acute graft-versus-host disease (GVHD), in pediatric haploidentical stem cell transplantation.
PATIENTS & METHODS:
The study population comprised 175 consecutive pediatric patients. Receiver operating characteristic analysis was performed to identify the cut-off CRP value.
RESULTS:
The high-CRP group (≥20.1 mg/l) was associated with an increased occurrence of engraftment syndrome (hazard ratio [HR] = 2.046; p = 0.008), II-IV acute GVHD (HR = 2.203; p = 0.001) and severe GVHD (HR = 6.371; p = 0.004).
CONCLUSION:
Our data suggest that higher CRP during the first 1-3 days post-transplant could be a predictor of allogeneic immune reactions.
AuthorsYao Chen, Xiao-Jun Huang, Kai-Yan Liu, Huan Chen, Yu-Hong Chen, Xiao-Hui Zhang, Yu Wang, Feng-Rong Wang, Wei Han, Jing-Zhi Wang, Chen-Hua Yan, Lan-Ping Xu
JournalBiomarkers in medicine (Biomark Med) Vol. 11 Issue 2 Pg. 117-124 (Feb 2017) ISSN: 1752-0371 [Electronic] England
PMID28111964 (Publication Type: Journal Article)
Chemical References
  • C-Reactive Protein
Topics
  • Adolescent
  • Area Under Curve
  • C-Reactive Protein (analysis)
  • Child
  • Child, Preschool
  • Female
  • Graft vs Host Disease (diagnosis, etiology, mortality)
  • Haplotypes
  • Hematopoietic Stem Cell Transplantation (adverse effects)
  • Humans
  • Immunity, Innate
  • Male
  • Proportional Hazards Models
  • ROC Curve
  • Risk Factors
  • Severity of Illness Index
  • Survival Rate
  • Time Factors
  • Transplantation, Homologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: